Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1974212rdf:typepubmed:Citationlld:pubmed
pubmed-article:1974212lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:1974212lifeskim:mentionsumls-concept:C0021368lld:lifeskim
pubmed-article:1974212lifeskim:mentionsumls-concept:C0439662lld:lifeskim
pubmed-article:1974212lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:1974212pubmed:dateCreated1990-9-13lld:pubmed
pubmed-article:1974212pubmed:abstractTextThe immunohistopathological findings of enucleated eyes and immunological abnormalities in several clinical disorders which result in intraocular inflammation are presented. With current immunological techniques, it is possible to define the type and activation status of the cells infiltrating the tissues. In all eyes examined, the predominant cell type was of activated CD4+ T-cells suggesting that the mechanisms involved in the perpetuation of the inflammatory response are similar and it is the initiating events which are likely to determine the site of pathology. The effects of activated CD4+ T-cells and the lymphokines they secrete in the chronic inflammatory process in the ocular tissues are discussed.lld:pubmed
pubmed-article:1974212pubmed:languageenglld:pubmed
pubmed-article:1974212pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1974212pubmed:citationSubsetIMlld:pubmed
pubmed-article:1974212pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1974212pubmed:statusMEDLINElld:pubmed
pubmed-article:1974212pubmed:issn0950-222Xlld:pubmed
pubmed-article:1974212pubmed:authorpubmed-author:ChanC CCClld:pubmed
pubmed-article:1974212pubmed:authorpubmed-author:LightmanSSlld:pubmed
pubmed-article:1974212pubmed:issnTypePrintlld:pubmed
pubmed-article:1974212pubmed:volume4 ( Pt 2)lld:pubmed
pubmed-article:1974212pubmed:ownerNLMlld:pubmed
pubmed-article:1974212pubmed:authorsCompleteYlld:pubmed
pubmed-article:1974212pubmed:pagination345-53lld:pubmed
pubmed-article:1974212pubmed:dateRevised2009-11-3lld:pubmed
pubmed-article:1974212pubmed:meshHeadingpubmed-meshheading:1974212-...lld:pubmed
pubmed-article:1974212pubmed:meshHeadingpubmed-meshheading:1974212-...lld:pubmed
pubmed-article:1974212pubmed:meshHeadingpubmed-meshheading:1974212-...lld:pubmed
pubmed-article:1974212pubmed:meshHeadingpubmed-meshheading:1974212-...lld:pubmed
pubmed-article:1974212pubmed:meshHeadingpubmed-meshheading:1974212-...lld:pubmed
pubmed-article:1974212pubmed:meshHeadingpubmed-meshheading:1974212-...lld:pubmed
pubmed-article:1974212pubmed:meshHeadingpubmed-meshheading:1974212-...lld:pubmed
pubmed-article:1974212pubmed:meshHeadingpubmed-meshheading:1974212-...lld:pubmed
pubmed-article:1974212pubmed:meshHeadingpubmed-meshheading:1974212-...lld:pubmed
pubmed-article:1974212pubmed:meshHeadingpubmed-meshheading:1974212-...lld:pubmed
pubmed-article:1974212pubmed:meshHeadingpubmed-meshheading:1974212-...lld:pubmed
pubmed-article:1974212pubmed:year1990lld:pubmed
pubmed-article:1974212pubmed:articleTitleImmune mechanisms in choroido-retinal inflammation in man.lld:pubmed
pubmed-article:1974212pubmed:affiliationInstitute of Ophthalmology, Moorfield's Eye Hospital, London.lld:pubmed
pubmed-article:1974212pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1974212pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1974212lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1974212lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1974212lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1974212lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1974212lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1974212lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1974212lld:pubmed